Article | September 15, 2017

Key Factors To Evaluate When Considering BYOD Clinical Trials

Source: Signant Health

Using eCOA to Capture Clinical Study Data
When making the switch from paper-based to electronic capture of Clinical Outcome Assessments (COA) data, there are a number of options that study teams must consider in terms of how the data is collected.

Traditionally, electronic Clinical Outcomes Assessments (eCOA) data has been captured via provisioned devices (i.e., devices that have been provided to participants). However, over recent years, there has been a rise in the number of sponsors and CROs interested in running Bring Your Own Device (BYOD) clinical trials due to the array of perceived benefits, as well as the increase in availability of technology.

While the move toward BYOD promises many advantages, including increased device familiarity, cost savings on devices, and improved accessibility for patients, it is certainly not a one-size-fits-all approach. There are a number of key  considerations that sponsors and CROs should be reviewing in order to evaluate the benefits of the methodology against the unique needs of each of their studies before deciding whether it is the most appropriate approach. As this eBook will make clear, the key to successful eCOA implementation of any kind (BYOD or provisioned) is through a focus on delivering a quality solution that meets the unique needs of patients and study teams.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader